Thomas P Lodise

Summary

Publications

  1. ncbi request reprint Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA
    Clin Infect Dis 44:357-63. 2007
  2. ncbi request reprint Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin 
    T P Lodise
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY, USA
    J Antimicrob Chemother 69:2547-55. 2014
  3. doi request reprint Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
    Thomas P Lodise
    Albany College of Pharmacy and Health Sciences, Albany, New York, NY 12208, USA
    Drugs 72:1473-93. 2012
  4. pmc Telavancin pharmacokinetics and pharmacodynamics in patients with complicated skin and skin structure infections and various degrees of renal function
    T P Lodise
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 56:2062-6. 2012
  5. pmc Penetration of vancomycin into epithelial lining fluid in healthy volunteers
    Thomas P Lodise
    Albany College of Pharmacy, Pharmacy Practice Department, Albany, New York 12208, USA
    Antimicrob Agents Chemother 55:5507-11. 2011
  6. doi request reprint Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients
    Thomas P Lodise
    Dept of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, Albany, NY 12208, USA
    Clin Infect Dis 49:507-14. 2009
  7. doi request reprint Use of pharmacodynamic principles to inform β-lactam dosing: "S" does not always mean success
    Thomas P Lodise
    Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    J Hosp Med 6:S16-23. 2011
  8. ncbi request reprint Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, Albany, NY, USA
    J Antimicrob Chemother 69:176-9. 2014
  9. doi request reprint The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia
    Vanessa Stevens
    Department of Pharmacy Practice, State University of New York School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA
    Infect Control Hosp Epidemiol 33:558-64. 2012
  10. pmc Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection
    Thomas P Lodise
    Albany College of Pharmacy, Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 51:3510-5. 2007

Collaborators

Detail Information

Publications48

  1. ncbi request reprint Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA
    Clin Infect Dis 44:357-63. 2007
    ..This study evaluates the clinical implications of extended infusion of piperacillin-tazobactam therapy for critically ill patients with P. aeruginosa infection...
  2. ncbi request reprint Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin 
    T P Lodise
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY, USA
    J Antimicrob Chemother 69:2547-55. 2014
    ..This study described the interrelationship between rVSPs and assessed their individual and combined effects on outcomes among patients who received vancomycin for a methicillin-resistant S. aureus (MRSA) bloodstream infection...
  3. doi request reprint Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
    Thomas P Lodise
    Albany College of Pharmacy and Health Sciences, Albany, New York, NY 12208, USA
    Drugs 72:1473-93. 2012
    ..It is a welcome treatment option for ABSSSI and CABP...
  4. pmc Telavancin pharmacokinetics and pharmacodynamics in patients with complicated skin and skin structure infections and various degrees of renal function
    T P Lodise
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 56:2062-6. 2012
    ..The comparable PTA profiles for the three dosing regimens across their respective dosing intervals indicate that the dose adjustments employed in phase III trials for complicated skin and skin structure infections were appropriate...
  5. pmc Penetration of vancomycin into epithelial lining fluid in healthy volunteers
    Thomas P Lodise
    Albany College of Pharmacy, Pharmacy Practice Department, Albany, New York 12208, USA
    Antimicrob Agents Chemother 55:5507-11. 2011
    ....
  6. doi request reprint Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients
    Thomas P Lodise
    Dept of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, Albany, NY 12208, USA
    Clin Infect Dis 49:507-14. 2009
    ..No study has been undertaken to determine the pharmacodynamic index (ie, the area under the curve [AUC] or the trough value) that best describes the relationship between vancomycin exposure and onset of nephrotoxicity...
  7. doi request reprint Use of pharmacodynamic principles to inform β-lactam dosing: "S" does not always mean success
    Thomas P Lodise
    Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    J Hosp Med 6:S16-23. 2011
    ....
  8. ncbi request reprint Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, Albany, NY, USA
    J Antimicrob Chemother 69:176-9. 2014
    ..The objectives of this study were to characterize the pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with CF and derive optimized piperacillin/tazobactam dosing recommendations...
  9. doi request reprint The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia
    Vanessa Stevens
    Department of Pharmacy Practice, State University of New York School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA
    Infect Control Hosp Epidemiol 33:558-64. 2012
    ..The aim of this study was to determine the ability of APACHE II to predict death at multiple time points among ICU and non-ICU patients with MRSA bacteremia...
  10. pmc Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection
    Thomas P Lodise
    Albany College of Pharmacy, Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 51:3510-5. 2007
    ..The data strongly suggest that delaying appropriate therapy for approximately 2 days significantly increases the risk of 30-day mortality in patients with P. aeruginosa bloodstream infections...
  11. pmc Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 57:864-72. 2013
    ..Given the high probability of C(min) being ≥ 24.3 mg/liter in one of the three studies, more intensive creatine phosphokinase (CPK) monitoring may be warranted in HD patients receiving daptomycin...
  12. pmc Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects
    Thomas P Lodise
    Ordway Research Institute, Albany, NY 12208, USA
    Antimicrob Agents Chemother 51:2378-87. 2007
    ..v. q12h, for patients who had a creatinine clearance rate of < or =50 ml/min, was identified as the most appropriate treatment regimen for patients who require renal dose adjustment for mild to moderate renal impairment...
  13. pmc Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA
    Antimicrob Agents Chemother 52:1330-6. 2008
    ..6 ml/min, and intensive care unit residence were independently associated with time to nephrotoxicity. The data suggest that higher-dose vancomycin regimens are associated with a higher likelihood of vancomycin-related nephrotoxicity...
  14. pmc Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation
    Thomas P Lodise
    Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 52:2300-4. 2008
    ..The median AUC(ELF)/free AUC(plasma) penetration ratio was 0.73, and the 25th and 75th percentile value ratios were 0.43 and 1.24, respectively. In uninfected lung tissue, the median AUC(ELF) is approximately 75% of the free AUC(plasma)...
  15. pmc Ertapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis
    Katie E Cardone
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 56:725-30. 2012
    ..v. q24h is very likely to achieve the exposure target associated with clinical efficacy in both the serum and peritoneal cavity against the range of MIC values deemed susceptible by the Clinical and Laboratory Standards Institute...
  16. pmc Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis
    Katie E Cardone
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA
    Clin J Am Soc Nephrol 6:1081-8. 2011
    ..daptomycin among patients receiving continuous ambulatory peritoneal dialysis (CAPD); (2) identify optimal i.v. CAPD dosing schemes; and (3) determine extent of daptomycin penetration into the peritoneal space after i.v. administration...
  17. doi request reprint A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin
    Nimish Patel
    Albany College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Albany, NY 12208, USA
    J Antimicrob Chemother 67:727-35. 2012
    ..The secondary objective was to assess the relationship between vancomycin trough concentration and adverse platelet outcomes...
  18. pmc Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa
    Nimish Patel
    Albany College of Pharmacy, Department of Pharmacy Practice, 106 New Scotland Avenue, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 52:2933-6. 2008
    ..When the specific antibiotic used was replaced by the number of prior exposures, the number of exposures was the only variable associated with an increased risk of antibiotic resistance at each time threshold...
  19. pmc Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
    Thomas P Lodise
    Albany College of Pharmacy, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 51:3731-3. 2007
    ....
  20. pmc Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia
    Thomas P Lodise
    Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 51:3977-82. 2007
    ..01]), but no difference in LOS was noted among PSI class V patients. Our study showed that improved outcomes may be realized with BL+M in cases of severe CAP. A randomized clinical study is warranted based on these results...
  21. doi request reprint Vancomycin: we can't get there from here
    Nimish Patel
    Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    Clin Infect Dis 52:969-74. 2011
    ..We sought to characterize the pharmacodynamic profile of the more intensive vancomycin dosing regimens currently used in response to the recent vancomycin guidelines...
  22. ncbi request reprint Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates
    Thomas P Lodise
    Pharmacy Practice Department, Albany College of Pharmacy, Albany, NY 12208, USA
    Infect Control Hosp Epidemiol 28:959-65. 2007
    ..aeruginosa infections and potentially maximize clinical outcomes by increasing the likelihood of appropriate empirical antimicrobial therapy...
  23. pmc Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    Antimicrob Agents Chemother 55:5433-7. 2011
    ..Identifying these institution-specific risk factors can be used to develop a process to assess the risk of agr dysfunction and guide empirical antibiotic therapy decisions...
  24. ncbi request reprint Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, New York 12208 3492, USA
    Pharmacotherapy 27:1001-12. 2007
    ..Further studies are needed to determine if these drugs can better eradicate MRSA than vancomycin and remedy the adverse outcomes frequently observed with this organism...
  25. ncbi request reprint Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?
    Thomas P Lodise
    Albany College of Pharmacy and Health Sciences, New York
    Clin Infect Dis 59:666-75. 2014
    ..However, scant clinical data exist to support this target and available data relied on pharmacokinetic formulas based on daily vancomycin dose and estimated renal function (demographic pharmacokinetic model) to estimate AUCs...
  26. ncbi request reprint Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomies
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA
    Diagn Microbiol Infect Dis 54:223-30. 2006
    ..03 and 8 microg/mL for each regimen examined. In CSF, none of the regimens achieved 50-100% T>MIC for>80% of patients for MICs>0.5 mg/L...
  27. pmc Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis
    Nimish Patel
    Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:1677-83. 2011
    ..For the 72-h interdialytic period, clinicians should consider increasing the dose by 50% to achieve more comparable AUC(48-72) values...
  28. pmc Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow-fiber infection model
    Anthony M Nicasio
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 56:682-6. 2012
    ..Overall, the results suggest that once-daily vancomycin administration is feasible from a PK/PD perspective and merits further inquiry in the clinical arena...
  29. pmc Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:4277-82. 2011
    ....
  30. doi request reprint Pharmacokinetic and pharmacodynamic profile of ceftobiprole
    Thomas P Lodise
    Albany College of Pharmacy, Albany, NY 12208, USA
    Diagn Microbiol Infect Dis 61:96-102. 2008
    ....
  31. ncbi request reprint Relationship between Time to Clinical Response and Outcomes among Pneumonia Outcomes Research Team (PORT) Risk Class III and IV Hospitalized Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and Azithromycin
    Evan Zasowski
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 58:3804-13. 2014
    ....
  32. ncbi request reprint Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York
    Clin Infect Dis 58:S28-34. 2014
    ..Pharmacokinetic (PK) data demonstrate that tedizolid penetrates well into the epithelial lining fluid (ELF) of the lung. Data from the pneumonia infection model and ELF penetration PK study support exploring its use in pneumonia. ..
  33. pmc Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin
    Kerry L LaPlante
    Anti Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Department of Pharmacy Practice, School of Medicine, Wayne State University, 259 Mack Ave, Detroit, MI 48201, USA
    Antimicrob Agents Chemother 51:1315-20. 2007
    ..002) than those of gatifloxacin. The order of resistance development determined from fAUC/MIC breakpoints was levofloxacin>gatifloxacin>moxifloxacin=gemifloxacin, which may be related to structural differences within the class...
  34. doi request reprint Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data
    Jill M Butterfield
    Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY, USA
    J Antimicrob Chemother 67:494-502. 2012
    ..All reported adverse events were evaluated for serotonin toxicity using exact and surrogate terms consistent with Sternbach Criteria and Hunter Serotonin Toxicity Criteria...
  35. doi request reprint Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit
    Thomas P Lodise
    Albany College of Pharmacy and Health Sciences, Albany, NY, USA
    Crit Care Clin 27:1-18. 2011
    ..Finally, we examine combination chemotherapy and strategies for optimizing the administration of multiple agents...
  36. ncbi request reprint Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists
    Thomas P Lodise
    Albany College of Pharmacy, Albany, New York 12208, USA
    Pharmacotherapy 26:1320-32. 2006
    ..Moreover, they achieved the targeted fT>MIC with less administration time/day than would be needed for continuous infusion...
  37. ncbi request reprint Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis
    Katie E Cardone
    Albany College of Pharmacy and Health Sciences, Albany, NY, USA
    J Antimicrob Chemother 69:1873-6. 2014
    ....
  38. pmc Pharmacokinetics and pharmacodynamics of once-daily administration of intravenous tobramycin in adult patients with cystic fibrosis hospitalized for an acute pulmonary exacerbation
    Jill M Butterfield
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 57:5175-7. 2013
    ..Empirical tobramycin regimens of ≥15 mg/kg of body weight administered i.v. once daily should be evaluated for adult patients with CF to optimize outcomes. ..
  39. pmc Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, Albany, New York 12208, USA
    Antimicrob Agents Chemother 55:5640-5. 2011
    ..Since the systemic exposure of oseltamivir carboxylate is not reduced in class III obese adults with standard doses, a dose increment of oseltamivir is likely to be unnecessary...
  40. pmc Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation
    Thomas P Lodise
    Albany College, Albany, New York, USA
    Antimicrob Agents Chemother 48:4718-24. 2004
    ..This study indicates that piperacillin-tazobactam should have utility for empirical therapy of hospital-onset infections...
  41. ncbi request reprint Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens
    Thomas P Lodise
    Albany College of Pharmacy, Albany Medical College, Albany, NY 12208, USA
    Diagn Microbiol Infect Dis 52:45-52. 2005
    ..1% for H. influenzae. This study demonstrated a relationship between telithromycin drug exposure and microbiological outcome. Telithromycin is expected to achieve the drug exposure breakpoint for the majority of isolates causing CAP...
  42. doi request reprint Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae
    Nimish Patel
    Pharmacy Practice Department, Albany College of Pharmacy and Health Sciences, Albany, NY 12208 3492, USA
    J Antimicrob Chemother 66:1600-8. 2011
    ..This study characterizes factors associated with CIRE among two different source populations...
  43. pmc Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance
    Thomas P Lodise
    Albany College of Pharmacy, Department of Pharmacy Practice, and Department of Pharmacy, Albany Medical Center Hospital, 106 New Scotland Avenue, Albany, NY 12208 3492, USA
    Antimicrob Agents Chemother 51:417-22. 2007
    ..aeruginosa respiratory tract infections at our institution. Identifying these risk factors enabled us to develop a prediction tool to assess the risk of resistance and thus guide empirical antibiotic therapy...
  44. doi request reprint Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success
    Nimish Patel
    Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA
    J Antimicrob Chemother 65:2285-90. 2010
    ..This review describes a methodology for optimally identifying dosage adjustments in patients with impaired renal function using extended-infusion piperacillin/tazobactam as an illustrative example...
  45. ncbi request reprint Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy
    Christopher D Miller
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, New York 12208, USA
    Pharmacotherapy 27:1379-86. 2007
    ....
  46. pmc Reevaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysis
    Katie E Cardone
    Albany College of Pharmacy and Health Sciences, Albany, New York, USA
    Antimicrob Agents Chemother 58:19-26. 2014
    ..Ceftazidime i.p. at 1.5 or 2 g q24h to q48h is recommended for nonperitoneal infections. For peritonitis, a 3-g load with maintenance dosing of 1 to 2 g i.p. q24h or 2 g i.p. q48h is recommended. ..
  47. pmc Steady-state plasma pharmacokinetics of oral voriconazole in obese adults
    Manjunath P Pai
    Albany College of Pharmacy and Health Sciences, 106 New Scotland Ave, O Brien 204, Albany, NY 12208, USA
    Antimicrob Agents Chemother 55:2601-5. 2011
    ..96) was identified between C(min) values and AUC(0-τ) values. Adjustment of voriconazole doses in individuals with class II obesity or greater does not appear to be necessary on the basis of body weight...
  48. ncbi request reprint Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
    Thomas P Lodise
    Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA
    Diagn Microbiol Infect Dis 52:113-22. 2005
    ..With the advent of new treatment options, the impact of MRSA will need to be revisited to determine if these therapies can remedy the increased morbidity associated with MRSA...